SKI Market

A+| A| A-|

Indian Indices

Sensex

76,784.70 -711.66
( -0.92%)

Global Indices

Nasdaq

48,888.32 -274.62
(-0.56%)

Dow Jones

7,157.73 -2.07
(-0.03%)

Hang Seng

59,153.23 -764.23
(-1.28%)

Nikkei 225

10,208.73 -124.06
(-1.20%)

Forex

USD-INR

94.52 0.35
(0.37%)

EUR-INR

110.65 0.18
(0.17%)

GBP-INR

127.71 0.18
(0.14%)

JPY-INR

0.59 0.00
(0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Wanbury Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524212

INE107F01022

30.7071971

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

WANBURY

13.97

903.18

EPS(TTM)

Face Value()

Div & Yield %

18.51

Back

Beardsell consolidated net profit declines 16.67% in the December 2025 quarter

Feb 11,2026

Net profit of Beardsell declined 16.67% to Rs 2.10 crore in the quarter ended December 2025 as against Rs 2.52 crore during the previous quarter ended December 2024. Sales rose 2.78% to Rs 66.59 crore in the quarter ended December 2025 as against Rs 64.79 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	66.59	64.79	3
OPM %	9.28	8.95	-
PBDT	5.46	5.17	6
PBT	3.52	3.33	6
NP	2.10	2.52	-17

76,784.70 -711.66 ( -0.92%)

48,888.32 -274.62 (-0.56%)

7,157.73 -2.07 (-0.03%)

59,153.23 -764.23 (-1.28%)

10,208.73 -124.06 (-1.20%)

94.52 0.35 (0.37%)

110.65 0.18 (0.17%)

127.71 0.18 (0.14%)

0.59 0.00 (0.25%)